Milestone Pharmaceuticals Inc. Common Shares (MIST)
Stock · NASDAQ · Health Care
$1.17as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$1.28
Industry
Biotechnology: Pharmaceutical Preparations
About MIST
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the ind…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 38
- Website
- www.milestonepharma.com
Fundamentals
- 1-day range
- $1.14$1.21
- Market cap
- $146.91M
- P/E (trailing)
- —
- P/E (forward)
- -1.50
- EPS (trailing)
- $-0.68
- Dividend yield
- —
- Beta
- 0.99
- Avg. volume
- 1.44M
52-week range
$1$3.06
Next earnings: November 12, 2026 · EPS estimate $-0.21confirmed
Forecasts
7 analyst ratings
Buy 83%
Hold 17%
Sell 0%
1-year price forecast
High
$8
+586.7%
Median
$7
+500.9%
Low
$2
+71.7%
Milestone Pharmaceuticals Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- MISTMilestone Pharmaceuticals Inc. Common Shares$1.17▼ 2.10%Market cap $146.91MP/E —$1$3.06
- ADCTADC Therapeutics SA Common Shares$1.15▲ 2.68%Market cap $143.73MP/E —$0.7796$4.98
- CNTNCanton Strategic Holdings Inc. Common Stock$2.23▼ 5.32%Market cap $143.45MP/E —$1.75$7.25
- NGENNervGen Pharma Corp. Common stock$2.27▼ 2.78%Market cap $141.37MP/E —$3.2$8.49
- KZIAKazia Therapeutics Limited American Depositary Shares$13.59▼ 19.59%Market cap $140.89MP/E —$4.86$17.4
- MENSJyong Biotech Ltd. Ordinary Shares$2.37▲ 3.04%Market cap $153.58MP/E —$1.43$67
- OGIOrganigram Global Inc. Common Shares$1.22▼ 0.81%Market cap $139.37MP/E —
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MIST Milestone Pharmaceuticals Inc. Common Shares | $146.91M | — | $1.17 | ▼ 2.10% | $1$3.06 |
| ADCT ADC Therapeutics SA Common Shares | $143.73M | — | $1.15 | ▲ 2.68% | $0.7796$4.98 |
| CNTN Canton Strategic Holdings Inc. Common Stock | $143.45M | — | $2.23 | ▼ 5.32% | $1.75$7.25 |
| NGEN NervGen Pharma Corp. Common stock | $141.37M | — | $2.27 | ▼ 2.78% | $3.2$8.49 |
| KZIA Kazia Therapeutics Limited American Depositary Shares | $140.89M | — | $13.59 | ▼ 19.59% | $4.86$17.4 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $153.58M | — | $2.37 | ▲ 3.04% | $1.43$67 |
| OGI Organigram Global Inc. Common Shares | $139.37M | — | $1.22 | ▼ 0.81% |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Milestone Pharmaceuticals Presenting Data In Moderated EPoster Session Titled 'he Impact of PSVT on Patients’ Daily Life and QoL in Between Episodes' At European Society Of Cardiology Congress 2026benzinga · 8/27/2026
- Milestone Pharmaceuticals Presenting Data In Moderated EPoster Session Titled 'he Impact of PSVT on Patients’ Daily Life and QoL in Between Episodes' At European Society Of Cardiology Congress 2026Benzinga · 8/27/2026
- This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · 8/20/2026
- Cantor Fitzgerald Initiates Coverage On Milestone Pharmaceuticals with Overweight Rating, Announces Price Target of $3Benzinga · 8/20/2026
- Milestone Pharmaceuticals: Reiterating Sell As The Losses CompoundSeekingAlpha · 8/18/2026
- Milestone Pharmaceuticals Inc. (MIST) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/12/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 8/12/2026
- Milestone Pharmaceuticals Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $559.000K Miss $816.667K EstimateBenzinga · 8/12/2026
Insider Activity
Insider Actions →Acquired
539.0K
Disposed
36.5K
- Duty Stuart · June 10, 2026 · Grant77.0K
- Robert James Wills · June 10, 2026 · Grant77.0K
- Saik Andrew · June 10, 2026 · Grant77.0K
- Fischer Seth H. Z. · June 10, 2026 · Grant77.0K
- Michael John Tomsicek · June 10, 2026 · Grant77.0K
- Lisa M. Giles · June 10, 2026 · Grant77.0K
- Joseph C. Papa · June 10, 2026 · Grant77.0K
- Joseph Oliveto · April 16, 2026 · Sale36.5K @ $2.26
Institutional Ownership
March 31, 2026
- Total shares held
- 30.09M
- Total value held
- $35.73M
- Institutional holders
- 84
Top holders this quarter
- Unknown6.33M
- Unknown4.12M
- Unknown2.32M
- Unknown2.00M
- Unknown1.94M
- Unknown1.54M
- Unknown1.51M
- Unknown1.09M
- Unknown851.3K
- Unknown820.0K
See the full, filterable feed with live charts on the MarketWall dashboard.